TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE) Following Expanded Novartis Deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. GO

Go back to TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE) Following Expanded Novartis Deal
(NASDAQ: GLUE) Delayed: 15.84 -0.11 (0.69%)
Previous Close $15.95    52 Week High $ 
Open $16.08    52 Week Low $ 
Day High $16.25    P/E N/A 
Day Low $15.79    EPS $ 
Volume 681,791